ZA9410189B - Novel stem cell factor formulations and methods - Google Patents

Novel stem cell factor formulations and methods

Info

Publication number: ZA9410189B
Authority: ZA; South Africa
Prior art keywords: stem cell; cell factor; methods; novel stem; factor formulations
Prior art date: 1993-12-22

Application number

ZA9410189A

Other languages

English (en)

Inventor

Susan I Hershenson

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-22

Filing date

1994-12-21

Publication date

1995-08-25

1994-12-21 Application filed by Amgen Inc filed Critical Amgen Inc

1995-08-25 Publication of ZA9410189B publication Critical patent/ZA9410189B/xx

Links

238000009472 formulation Methods 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
210000000130 stem cell Anatomy 0.000 title abstract 2
238000000034 method Methods 0.000 title 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
229930195725 Mannitol Natural products 0.000 abstract 1
229930006000 Sucrose Natural products 0.000 abstract 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
235000013922 glutamic acid Nutrition 0.000 abstract 1
239000004220 glutamic acid Substances 0.000 abstract 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
239000000594 mannitol Substances 0.000 abstract 1
235000010355 mannitol Nutrition 0.000 abstract 1
239000005720 sucrose Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ZA9410189A 1993-12-22 1994-12-21 Novel stem cell factor formulations and methods ZA9410189B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/172,507 US6288030B1 (en)	1993-12-22	1993-12-22	Stem cell factor formulations and methods

Publications (1)

Publication Number	Publication Date
ZA9410189B true ZA9410189B (en)	1995-08-25

Family

ID=22627993

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9410189A ZA9410189B (en)	1993-12-22	1994-12-21	Novel stem cell factor formulations and methods

Country Status (13)

Country	Link
US (4)	US6288030B1 (fr)
EP (1)	EP0732935B1 (fr)
CN (1)	CN1105575C (fr)
AT (1)	ATE173402T1 (fr)
AU (1)	AU696860B2 (fr)
CA (1)	CA2182970C (fr)
DE (1)	DE69414723T2 (fr)
DK (1)	DK0732935T3 (fr)
ES (1)	ES2123951T3 (fr)
IL (1)	IL112088A (fr)
NZ (1)	NZ278252A (fr)
WO (1)	WO1995017206A1 (fr)
ZA (1)	ZA9410189B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6267958B1 (en)	1995-07-27	2001-07-31	Genentech, Inc.	Protein formulation
GB9515839D0 (en) *	1995-08-02	1995-10-04	Q One Biotech Ltd	Feline stem cell factor
TW518219B (en) *	1996-04-26	2003-01-21	Chugai Pharmaceutical Co Ltd	Erythropoietin solution preparation
US6017876A (en)	1997-08-15	2000-01-25	Amgen Inc.	Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity
US6541033B1 (en)	1998-06-30	2003-04-01	Amgen Inc.	Thermosensitive biodegradable hydrogels for sustained delivery of leptin
US6420339B1 (en)	1998-10-14	2002-07-16	Amgen Inc.	Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US6245740B1 (en)	1998-12-23	2001-06-12	Amgen Inc.	Polyol:oil suspensions for the sustained release of proteins
US6500418B1 (en) *	1999-02-12	2002-12-31	The Washington University	Stimulating neutrophil function to treat inflammatory bowel disease
US8106098B2 (en)	1999-08-09	2012-01-31	The General Hospital Corporation	Protein conjugates with a water-soluble biocompatible, biodegradable polymer
US6472208B1 (en) *	1999-12-13	2002-10-29	Héma-Québec	Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
MXPA03005014A (es) *	2000-12-06	2004-09-10	Robert J Hariri	Metodo para recolectar celulas madres de la placenta.
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
AU2002251935B2 (en)	2001-02-14	2007-11-29	Celularity Inc.	Post-partum mammalian placenta, its use and placental stem cells therefrom
US20030191056A1 (en)	2002-04-04	2003-10-09	Kenneth Walker	Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
JP3963786B2 (ja) *	2002-06-11	2007-08-22	富士通株式会社	情報処理装置
AU2003298775B2 (en) *	2002-11-26	2008-07-17	Anthrogenesis Corporation	Cytotherapeutics, cytotherapeutic units and methods for treatments using them
NZ566132A (en) *	2003-02-13	2009-09-25	Anthrogenesis Corp	Use of umbilical cord blood to treat inflammation, ParkinsonÆs disease or diabetes
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
BRPI0417186A (pt) *	2003-12-02	2007-03-06	Celgene Corp	método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica
CA2552241C (fr)	2003-12-30	2013-10-01	Durect Corporation	Dispositifs copolymeriques pour la liberation controlee d'agents actifs
JP2008543839A (ja)	2005-06-14	2008-12-04	アムジェンインコーポレーテッド	自己緩衝タンパク質製剤
CA2615731A1 (fr) *	2005-07-29	2007-02-08	Amgen Inc.	Formulations inhibant l'agregation de proteines
EP1957633B1 (fr)	2005-10-13	2013-12-18	Anthrogenesis Corporation	Immunomodulation realisee avec des cellules souches placentaires
AU2006332679A1 (en)	2005-12-29	2007-07-12	Anthrogenesis Corporation	Co-culture of placental stem cells and stem cells from a second source
KR20180105266A (ko)	2005-12-29	2018-09-27	안트로제네시스 코포레이션	태반 줄기 세포 집단
AR059066A1 (es)	2006-01-27	2008-03-12	Amgen Inc	Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
EP1854478A1 (fr) *	2006-05-12	2007-11-14	Cytos Biotechnology AG	Composition vaccinale comprenant des conjugués nicotine-porteur
NZ606814A (en)	2006-10-23	2014-10-31	Anthrogenesis Corp	Methods and compositions for treatment of bone defects with placental cell populations
CN103356710A (zh) *	2007-02-12	2013-10-23	人类起源公司	利用胎盘干细胞治疗炎性疾病
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
TWM322542U (en) *	2007-05-23	2007-11-21	Universal Scient Ind Co Ltd	Testing machine
US9200253B1 (en)	2007-08-06	2015-12-01	Anthrogenesis Corporation	Method of producing erythrocytes
KR20200136051A (ko) *	2007-09-26	2020-12-04	안트로제네시스 코포레이션	인간 태반 관류액으로부터의 혈관형성 세포
EP2203176B1 (fr)	2007-09-28	2014-11-26	Anthrogenesis Corporation	Elimination des tumeurs au moyen d'un perfusat placentaire humain et de cellules tueuses naturelles intermediaires provenant d'un placenta humain
AU2008325142A1 (en) *	2007-11-07	2009-05-14	Anthrogenesis Corporation	Use of umbilical cord blood in the treatment of premature birth complications
NZ591292A (en) *	2008-08-20	2012-10-26	Anthrogenesis Corp	Improved cell composition and methods of making the same
CA2734237C (fr) *	2008-08-20	2019-07-02	Anthrogenesis Corporation	Traitement d'un accident vasculaire cerebral a l'aide de cellules placentaires isolees
SI2331109T1 (sl) *	2008-08-22	2013-10-30	Anthrogenesis Corporation	Postopki in sestavki za zdravljenje okvar kosti s populacijami placentarnih celic
WO2010059828A1 (fr)	2008-11-19	2010-05-27	Anthrogenesis Corporation	Cellules adhérentes issues de l'amnios
EP2375907B1 (fr) *	2008-11-21	2019-02-27	Celularity, Inc.	Traitement de maladies, troubles ou états du poumon utilisant des cellules placentaires
EP2449095A1 (fr) *	2009-07-02	2012-05-09	Anthrogenesis Corporation	Procédé pour produire des érythrocytes sans cellules nourricières
CA2787992A1 (fr) *	2010-01-26	2011-08-04	Anthrogenesis Corporation	Traitement de cancers associes aux os utilisant des cellules souches placentaires
PL2556145T3 (pl)	2010-04-07	2017-02-28	Anthrogenesis Corporation	Angiogeneza z zastosowaniem łożyskowych komórek macierzystych
KR20130092394A (ko)	2010-04-08	2013-08-20	안트로제네시스 코포레이션	태반 줄기 세포를 사용한 사르코이드증의 치료
MX342995B (es)	2010-07-13	2016-10-21	Anthrogenesis Corp	Métodos de generar células asesinas naturales.
MX349054B (es)	2010-09-28	2017-07-07	Aegerion Pharmaceuticals Inc	Leptinas altamente solubles.
US8969315B2 (en)	2010-12-31	2015-03-03	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory RNA molecules
DK2714059T3 (en)	2011-06-01	2019-01-21	Celularity Inc	TREATMENT OF PAIN WHEN USING PLACENT STAM CELLS
WO2013055476A1 (fr)	2011-09-09	2013-04-18	Anthrogenesis Corporation	Traitement de la sclérose latérale amyotrophique au moyen de cellules souches placentaires
EP3622960A1 (fr)	2013-02-05	2020-03-18	Celularity, Inc.	Cellules tueuses naturelles placentaires
ES2964640T3 (es)	2015-08-13	2024-04-08	Amgen Inc	Filtración en profundidad cargada de proteínas de unión al antígeno

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4165370A (en)	1976-05-21	1979-08-21	Coval M L	Injectable gamma globulin
JPS5534001A (en) *	1978-08-28	1980-03-10	Noda Sangyo Kagaku Kenkyusho	Stabilization of sarcosine oxidase
US4783441A (en)	1979-04-30	1988-11-08	Hoechst Aktiengesellschaft	Aqueous protein solutions stable to denaturation
DE3176491D1 (en)	1980-03-05	1987-11-26	Miles Lab	Pasteurized therapeutically active protein compositions
JPS5874617A (ja)	1981-10-28	1983-05-06	Green Cross Corp:The	人由来血液凝固第７因子含有水溶液の加熱処理方法
JPS58134991A (ja) *	1981-12-28	1983-08-11	Takeda Chem Ind Ltd	セラチオペプチタ−ゼの安定化法
JPS59134730A (ja)	1983-01-20	1984-08-02	Green Cross Corp:The	血液凝固第８因子の加熱処理法
IL74909A (en)	1984-04-20	1992-01-15	Genentech Inc	Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
SE8501050D0 (sv)	1985-03-05	1985-03-05	Kabivitrum Ab	Biologically active fragments of human antihemophilic factor and method for preparation thereof
CA1292686C (fr)	1986-10-27	1991-12-03	Ze'ev Shaked	Compositions pharmaceutiques d'interleukine-2 recombinante et procede de fabrication
NZ226170A (en)	1987-09-18	1990-07-26	Ethicon Inc	Stable freeze-dried pharmaceutical composition containing epidermal growth factor
CA1329760C (fr) *	1987-10-29	1994-05-24	Ted C. K. Lee	Formulation de plasma et de proteines recombinantes dans des milieux a grande force ionique
US4877608A (en)	1987-11-09	1989-10-31	Rorer Pharmaceutical Corporation	Pharmaceutical plasma protein formulations in low ionic strength media
US5096885A (en)	1988-04-15	1992-03-17	Genentech, Inc.	Human growth hormone formulation
ATE108326T1 (de)	1989-01-30	1994-07-15	Corint Ltd	Wässerige desmopressin-cmc enthaltende arzneizubereitung.
JPH02268681A (ja) *	1989-04-07	1990-11-02	Green Cross Corp:The	ウロキナーゼ前駆体の安定化方法及び乾燥製剤
CA2028848A1 (fr) *	1989-04-11	1990-10-12	Tapan Audhya	Formulations de peptides lyophilises
EP0676470A1 (fr)	1989-10-16	1995-10-11	Amgen Inc.	Facteur de stimulation des cellules souches
HUT62011A (en)	1989-10-16	1993-03-29	Amgen Inc	Process for producing factors influencing the functioning of stem cells
SE465222C5 (sv)	1989-12-15	1998-02-10	Pharmacia & Upjohn Ab	Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
DE4001451A1 (de)	1990-01-19	1991-08-01	Octapharma Ag	Stabile injizierbare loesungen von faktor viii und faktor ix
EP0536317A1 (fr)	1990-06-25	1993-04-14	Immunex Corporation	Facteur de croissance de mastocytes
DE10399015I1 (de) *	1991-12-20	2012-05-03	Novo Nordisk As	Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
US5192743A (en)	1992-01-16	1993-03-09	Genentech, Inc.	Reconstitutable lyophilized protein formulation
ATE198277T1 (de) *	1992-10-02	2001-01-15	Genetics Inst	Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator

1993
- 1993-12-22 US US08/172,507 patent/US6288030B1/en not_active Expired - Fee Related
1994
- 1994-12-20 IL IL11208894A patent/IL112088A/en not_active IP Right Cessation
- 1994-12-21 ZA ZA9410189A patent/ZA9410189B/xx unknown
- 1994-12-21 AT AT95906058T patent/ATE173402T1/de not_active IP Right Cessation
- 1994-12-21 NZ NZ278252A patent/NZ278252A/en not_active IP Right Cessation
- 1994-12-21 ES ES95906058T patent/ES2123951T3/es not_active Expired - Lifetime
- 1994-12-21 WO PCT/US1994/014739 patent/WO1995017206A1/fr not_active Ceased
- 1994-12-21 DE DE69414723T patent/DE69414723T2/de not_active Expired - Lifetime
- 1994-12-21 CN CN94195012A patent/CN1105575C/zh not_active Expired - Fee Related
- 1994-12-21 AU AU14422/95A patent/AU696860B2/en not_active Ceased
- 1994-12-21 EP EP95906058A patent/EP0732935B1/fr not_active Expired - Lifetime
- 1994-12-21 DK DK95906058T patent/DK0732935T3/da active
- 1994-12-21 CA CA002182970A patent/CA2182970C/fr not_active Expired - Fee Related
1998
- 1998-06-29 US US09/106,891 patent/US5965522A/en not_active Expired - Fee Related
1999
- 1999-04-15 US US09/292,222 patent/US6020469A/en not_active Expired - Fee Related
2000
- 2000-12-20 US US09/748,592 patent/US20020013258A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE69414723D1 (de)	1998-12-24
US6020469A (en)	2000-02-01
CN1105575C (zh)	2003-04-16
US20020013258A1 (en)	2002-01-31
EP0732935A1 (fr)	1996-09-25
NZ278252A (en)	1998-04-27
DE69414723T2 (de)	1999-07-22
AU1442295A (en)	1995-07-10
ES2123951T3 (es)	1999-01-16
HK1008815A1 (en)	1999-05-21
US6288030B1 (en)	2001-09-11
US5965522A (en)	1999-10-12
IL112088A0 (en)	1995-03-15
CA2182970A1 (fr)	1995-06-29
EP0732935B1 (fr)	1998-11-18
CN1142771A (zh)	1997-02-12
DK0732935T3 (da)	1999-08-02
WO1995017206A1 (fr)	1995-06-29
CA2182970C (fr)	2000-11-28
ATE173402T1 (de)	1998-12-15
AU696860B2 (en)	1998-09-17
IL112088A (en)	2001-04-30

Publication	Publication Date	Title
IL112088A0 (en)	1995-03-15	Novel stem cell factor formulations and methods
AU1777495A (en)	1995-11-16	Stable freeze-dried formulation comprising a protein; assay kit
WO1995013297A3 (fr)	1995-06-15	Compositions immunogenes ameliorees agissant contre la gastrine humaine 17
AU1750097A (en)	1997-08-20	Highly concentrated, lyophilized, and liquid factor ix formulations
CA2191213A1 (fr)	1995-12-07	Souches de lactobacillus d'origine humaine, leurs compositions et leurs utilisations
DE3586697D1 (en)	1992-11-05	Aktive thymopentin-analoga.
EP0182372A3 (fr)	1988-09-14	Polypeptides facteur VIII coagulant
HU9400252D0 (en)	1994-05-30	Bpc peptides, their preparation and use
MX9708426A (es)	1998-08-30	Polipeptido hk2 de variante estable.
AU6645294A (en)	1994-11-21	L-amino acid oxidase
AU570572B2 (en)	1988-03-17	4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
IE873239L (en)	1988-06-01	Variants of hirudin
CA2176223A1 (fr)	1995-05-18	Formulations a base de fenbendazole
PH31219A (en)	1998-05-05	Stable lyophilized thiotepa composition.
IT8523026A0 (it)	1985-11-29	Procedimento per la fabbricazione di coperchi valvole di compressori.
BG103412A (en)	2000-06-30	Stabilized pharmaceutical compositions based on chinupristine and dalfopristine and their preparation
CA2115151A1 (fr)	1993-02-18	Proteines kinases pk40 et pk36 de tau/neurofilaments
NZ326769A (en)	2000-05-26	High-content famciclovir tablets
AU1518688A (en)	1988-11-17	Stable creatine amidinohydrolase mutants
AU7969187A (en)	1988-04-07	Amino acid composition
EP0219716A3 (fr)	1988-03-30	Agent immunosuppresseur
AU2170695A (en)	1995-09-14	Cloned glutamic acid decarboxylase
MX9705959A (es)	1997-11-29	Formulaciones para il-12.
AU3573193A (en)	1993-10-05	Recombinant plant enzyme